1. Home
  2. IMNM vs HELE Comparison

IMNM vs HELE Comparison

Compare IMNM & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • HELE
  • Stock Information
  • Founded
  • IMNM 2006
  • HELE 1968
  • Country
  • IMNM United States
  • HELE United States
  • Employees
  • IMNM N/A
  • HELE N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • HELE Home Furnishings
  • Sector
  • IMNM Health Care
  • HELE Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • HELE Nasdaq
  • Market Cap
  • IMNM 748.3M
  • HELE 642.2M
  • IPO Year
  • IMNM 2020
  • HELE N/A
  • Fundamental
  • Price
  • IMNM $8.75
  • HELE $26.73
  • Analyst Decision
  • IMNM Strong Buy
  • HELE Buy
  • Analyst Count
  • IMNM 5
  • HELE 3
  • Target Price
  • IMNM $26.40
  • HELE $56.33
  • AVG Volume (30 Days)
  • IMNM 874.4K
  • HELE 603.9K
  • Earning Date
  • IMNM 08-11-2025
  • HELE 07-08-2025
  • Dividend Yield
  • IMNM N/A
  • HELE N/A
  • EPS Growth
  • IMNM N/A
  • HELE N/A
  • EPS
  • IMNM N/A
  • HELE 5.37
  • Revenue
  • IMNM $10,938,000.00
  • HELE $1,907,665,000.00
  • Revenue This Year
  • IMNM N/A
  • HELE $0.44
  • Revenue Next Year
  • IMNM $349.38
  • HELE $0.99
  • P/E Ratio
  • IMNM N/A
  • HELE $4.98
  • Revenue Growth
  • IMNM N/A
  • HELE N/A
  • 52 Week Low
  • IMNM $5.15
  • HELE $24.15
  • 52 Week High
  • IMNM $16.81
  • HELE $100.65
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 48.43
  • HELE 43.16
  • Support Level
  • IMNM $9.02
  • HELE $25.93
  • Resistance Level
  • IMNM $9.91
  • HELE $28.18
  • Average True Range (ATR)
  • IMNM 0.55
  • HELE 1.24
  • MACD
  • IMNM -0.08
  • HELE 0.11
  • Stochastic Oscillator
  • IMNM 9.37
  • HELE 27.25

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: